These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 25427730)

  • 1. Transarterial chemoembolization failure/refractoriness: JSH-LCSGJ criteria 2014 update.
    Kudo M; Matsui O; Izumi N; Kadoya M; Okusaka T; Miyayama S; Yamakado K; Tsuchiya K; Ueshima K; Hiraoka A; Ikeda M; Ogasawara S; Yamashita T; Minami T;
    Oncology; 2014; 87 Suppl 1():22-31. PubMed ID: 25427730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the criteria of transcatheter arterial chemoembolization failure or refractoriness in patients with advanced hepatocellular carcinoma proposed by the LCSGJ.
    Arizumi T; Ueshima K; Chishina H; Kono M; Takita M; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Sakurai T; Nishida N; Kudo M
    Oncology; 2014; 87 Suppl 1():32-6. PubMed ID: 25427731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.
    Takayasu K; Arii S; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Kokudo N; Makuuchi M
    J Hepatol; 2012 Apr; 56(4):886-92. PubMed ID: 22173160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion.
    de Baere T; Arai Y; Lencioni R; Geschwind JF; Rilling W; Salem R; Matsui O; Soulen MC
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):334-43. PubMed ID: 26390875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?
    Sacco R; Antonucci M; Bargellini I; Marceglia S; Mismas V; Cabibbo G
    Future Oncol; 2015; 11(17):2371-3. PubMed ID: 26270206
    [No Abstract]   [Full Text] [Related]  

  • 6. Current status of hepatocellular carcinoma treatment in Japan: transarterial chemoembolization.
    Matsui O
    Clin Drug Investig; 2012 Aug; 32 Suppl 2():3-13. PubMed ID: 22873623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.
    Pinter M; Hucke F; Graziadei I; Vogel W; Maieron A; Königsberg R; Stauber R; Grünberger B; Müller C; Kölblinger C; Peck-Radosavljevic M; Sieghart W
    Radiology; 2012 May; 263(2):590-9. PubMed ID: 22438359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of sorafenib in intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization.
    Ogasawara S; Chiba T; Ooka Y; Kanogawa N; Motoyama T; Suzuki E; Tawada A; Kanai F; Yoshikawa M; Yokosuka O
    Oncology; 2014; 87(6):330-41. PubMed ID: 25227534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial chemoembolization for hepatocellular carcinoma: An old method, now flavor of the day.
    Boulin M; Delhom E; Pierredon-Foulongne MA; Cercueil JP; Guiu B
    Diagn Interv Imaging; 2015 Jun; 96(6):607-15. PubMed ID: 25998996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.
    Hiraoka A; Ishimaru Y; Kawasaki H; Aibiki T; Okudaira T; Toshimori A; Kawamura T; Yamago H; Nakahara H; Suga Y; Azemoto N; Miyata H; Miyamoto Y; Ninomiya T; Hirooka M; Abe M; Matsuura B; Hiasa Y; Michitaka K
    Oncology; 2015; 89(3):167-74. PubMed ID: 25999038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization.
    Chen CS; Li FK; Guo CY; Xiao JC; Hu HT; Cheng HT; Zheng L; Zong DW; Ma JL; Jiang L; Li HL
    Oncotarget; 2016 Feb; 7(6):7241-52. PubMed ID: 26769845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of local hepatic therapy to sorafenib in patients with advanced hepatocellular carcinoma (stage BCLC C).
    Schmidt L; op den Winkel M; Fischer K; Straub G; Rauch B; Paprottka PM; Göke B; Kolligs FT
    Digestion; 2014; 90(4):219-28. PubMed ID: 25502689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superselective transarterial chemoembolization for hepatocellular carcinoma: recent progression and perspective.
    Takayasu K
    Oncology; 2011; 81 Suppl 1():105-10. PubMed ID: 22212943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma.
    Kim SS; Nam JS; Cho HJ; Won JH; Kim JW; Ji JH; Yang MJ; Park JH; Noh CK; Shin SJ; Lee KM; Cho SW; Cheong JY
    J Gastroenterol Hepatol; 2017 Jan; 32(1):199-207. PubMed ID: 27194671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinoma.
    Kim HY; Park JW; Joo J; Jung SJ; An S; Woo SM; Kim HB; Koh YH; Lee WJ; Kim CM
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1051-6. PubMed ID: 22098152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: a cross-sectional survey of techniques.
    Young S; Craig P; Golzarian J
    Eur Radiol; 2019 Jun; 29(6):3287-3295. PubMed ID: 30350163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial chemoembolization for hepatocellular carcinoma: significance of extrahepatic collateral supply.
    Paul SB; Gamanagatti SR; Mukund A; Abbas SZ; Acharya SK
    Indian J Cancer; 2011; 48(3):339-44. PubMed ID: 21921335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open-Label Single-Arm Phase II Trial of Sorafenib Therapy with Drug-eluting Bead Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma: Clinical Results.
    Cosgrove DP; Reyes DK; Pawlik TM; Feng AL; Kamel IR; Geschwind JF
    Radiology; 2015 Nov; 277(2):594-603. PubMed ID: 26069923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventional oncology: new options for interstitial treatments and intravascular approaches: superselective TACE using iodized oil for HCC: rationale, technique and outcome.
    Matsui O; Miyayama S; Sanada J; Kobayashi S; Khoda W; Minami T; Kozaka K; Gabata T
    J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):407-9. PubMed ID: 19885639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt.
    Kang JW; Kim JH; Ko GY; Gwon DI; Yoon HK; Sung KB
    Acta Radiol; 2012 Jun; 53(5):545-50. PubMed ID: 22547388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.